Podcast: Assessing the EMA's new innovative medical device pathway pilot

A key component of the EMA's innovative device pathway is to offer expert support to manufacturers of breakthrough medical devices. A key component of the EMA's innovative device pathway is to offer expert support to manufacturers of breakthrough medical devices. The EMA’s pilot launched on 28 April 2026. Credit: Lubo Ivanko / Shutterstock.com On 28 April 2026, the European Medicines Agency (EMA) launched a pilot pathway designed to support the development of breakthrough medical devices in the European Union (EU). The agency’s intent is for the new pathway to support patient access to ‘highly innovative’ medical technologies. Artificial Intelligence in…

Source: Medical Device Network